Biopol Chemicals Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Net Income	89.74	43.3	12.81
Depreciation & Amortization	0.98	0.7	0.4
Other Amortization	15.21	0.01	0.01
Other Operating Activities	27.43	16.64	4.25
Change in Accounts Receivable	-110.98	-65.25	-61.58
Change in Inventory	-77.93	-56.81	-61.33
Change in Accounts Payable	-21.66	47.21	19.44
Change in Other Net Operating Assets	-50.45	-9.16	-2.71
Operating Cash Flow	-127.66	-23.37	-88.72
Capital Expenditures	-142	-0.25	-0.71
Sale of Property, Plant & Equipment	-	-	0
Sale (Purchase) of Intangibles	-0.03	-	-
Other Investing Activities	0.32	-	-
Investing Cash Flow	-145.3	-0.25	-0.71
Short-Term Debt Issued	-	34.79	35.77
Long-Term Debt Issued	76.29	6.3	-
Total Debt Issued	76.29	41.09	35.77
Short-Term Debt Repaid	-68.13	-	-
Long-Term Debt Repaid	-0.37	-	-
Total Debt Repaid	-68.5	-	-
Net Debt Issued (Repaid)	7.8	41.09	35.77
Issuance of Common Stock	312.6	-	55.73
Other Financing Activities	-53.73	-6.82	-1.24
Financing Cash Flow	266.66	34.27	90.25
Miscellaneous Cash Flow Adjustments	0	-	-
Net Cash Flow	-6.3	10.66	0.82
Free Cash Flow	-269.66	-23.61	-89.43
Free Cash Flow Margin	-33.14%	-4.81%	-51.30%
Free Cash Flow Per Share	-32.54	-2.98	-
Cash Interest Paid	-	5.05	0.81
Cash Income Tax Paid	-	4.83	1.32
Levered Free Cash Flow	-283.71	-36.4	-
Unlevered Free Cash Flow	-289.41	-33.24	-
Change in Working Capital	-261.02	-84.02	-106.18

Source: S&P Global Market Intelligence. Standard template. Financial Sources.